MedTrace Logo

NYU Ovarian Cancer Early Detection Program Blood and Genetics

NCT00531778 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 890

Last updated 2011-01-11

No results posted yet for this study

Summary

Improving current strategies for detection of early stage disease can impact favorably on long-term survival of women with ovarian cancer. To reduce the morbidity and mortality of ovarian cancer, screening for this disease must detect early stage disease rather than advanced stage disease. Thus the challenge for the future is to identify and develop highly sensitive and specific tumor markers that can be applied to population-based screening for the early detection of ovarian cancer.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Bhavana Pothuri, M.D. · NYU Langone Health

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Completion
2010-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00531778 on ClinicalTrials.gov